Tuesday, July 12, 2016

Juno Therapeutics Re-Starts Cancer Trial After Deaths Put Study on Hold

Juno Therapeutics has been given the green light to re-start a cancer clinical trial less than a week after regulators put it on hold because of three patient deaths.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)